| LY2409881 trihydrochloride |
IKK2抑制剂（LY2409881） |
946518-60-1 |
| SCH772984 |
(R)-1-(2--2-氧(4-(4-(嘧啶-2-基)苯基)对二氮己环-1-基)乙基)-N-(3-(吡啶-4-基)-1H--5INDAZOL-基)吡咯烷-3-甲酰胺 |
942183-80-4 |
| KU-0063794 |
KU-0063794 |
938440-64-3 |
| PACRITINIB |
帕克替尼 |
937272-79-2 |
| OSI-027 |
反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-F][1,2,4]三嗪-7-基]环己烷羧酸 |
936890-98-1 |
| Ibrutinib |
依鲁替尼 |
936563-96-1 |
| 5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine |
5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺 |
935666-88-9 |
| Mycro3 |
944547-46-0 |
944547-46-0 |
| 3-CinnolinecarboxaMide, 4-aMino-8-(2-fluoro-6-Methoxyphenyl)-N-propyl- |
3-CinnolinecarboxaMide, 4-aMino-8-(2-fluoro-6-Methoxyphenyl)-N-propyl- |
942437-37-8 |
| N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide |
N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺 |
936091-14-4 |
| SAR245409 |
VOXTALISIB |
934493-76-2 |
| SAR407899 |
SAR407899 |
923359-38-0 |
| Nilotinib Hydrochloride Monohydrate |
盐酸尼罗替尼一水合物 |
923288-90-8 |
| IDO-IN-1 |
4-氨基-N-(3-溴-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 |
914638-30-5 |
| YHO-13177 |
CS-2881 |
912287-56-0 |
| SLx-2119 |
2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-异丙基乙酰胺 |
911417-87-3 |
| indoleaMine-2,3-dioxygenase inhibitor INCB024360 |
4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 |
914471-09-3 |
| 4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide |
SNX-2112;4-(6,6-DIMETHYL-4-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-INDAZOL-1-YL)-2-((1R,4R)-4-HYDROXYCYCLOHEXYLAMINO)BENZAMIDE |
908112-43-6 |
| Teneligliptin |
氢溴酸替格列汀 |
906093-29-6 |
| PFI-4 |
N-(1,3-二甲基-2-氧代-6-(吡咯烷-1-基)-2,3-二氢-1H-苯并[D]咪唑-5-基)-2-甲氧基苯甲酰胺 |
900305-37-5 |
QQ
